Inside a 100% YoY Growth Company ($NXGL: Nexgel)

Описание: In this conversation, Adam Levy shares his journey from the music industry to leading NextGel, a company specializing in innovative hydrogels. He discusses the unique technology behind their products, the challenges of FDA approval, and the competitive landscape of the hydrogel market. Adam emphasizes the importance of partnerships, customer acquisition, and the company's growth strategy, including their focus on consumer products. He also addresses financial metrics, risks, and the long-term vision for NextGel, highlighting the significance of effective investor relations and communication.

Connect with me:
Linkedin -   / david-barbato  
X - https://x.com/Valuehunte
Website - www.value-bridge.co
Spotify - https://open.spotify.com/show/7jWVlCZ...

Sponsor:
MicroCap Club: https://microcapclub.com/

Legal Disclaimer: Not Financial Advice

The information provided in this interview is for informational and educational purposes only and should not be considered legal, financial, or investment advice. I am not a financial advisor, and nothing discussed should be interpreted as a recommendation to buy, sell, or hold any financial asset or security.

Additionally, I do not promote any stocks, investment opportunities, or financial products. I have not received any compensation, payment, or incentive, financial or otherwise, for participating in this interview. I do own shares in NGXL as of 16/10/25

Always conduct your own research and consult with a qualified professional before making any financial or investment decisions.

Connect with my Trailer Editor, Borys:
Instagram -   / borysfilms  

Chapters

00:00 Introduction and Background of Adam
03:52 Transition from Music to Medical Technology
06:50 Understanding NextGel's Hydrogel Technology
09:49 Market Position and Unique Selling Proposition
12:48 Industry Overview and Competitors
15:48 FDA Approval Process and Regulatory Challenges
18:36 Intellectual Property and Trade Secrets
21:24 Consumer Products and Revenue Growth
24:20 Acquisition Strategy and Financial Metrics
27:33 Customer Acquisition and Onboarding Process
30:31 Partnerships and Future Prospects with AbbVie
38:05 Unit Economics and Partnership Insights
40:18 Navigating Challenges Without Avvi
42:27 Competitive Landscape and Market Positioning
43:20 Exploring Adjacent Markets and Applications
45:32 Financial Projections and Capital Allocation
48:28 Dilution Risks and Strategic Financing
52:32 Stada Partnership and Product Development
55:22 Marketing Insights from Past Experiences
01:01:31 Long-term Vision and Innovation Strategies
01:09:24 Investor Relations and Communication Strategy